FDA Clearance Tracker · K251138
Promisemed Safety Huber Needles
Last checked: Nov 20, 2026Latest source record: May 13, 2025 (this decision)Source: openFDAMethods & limitations
Decided
May 13, 2025
Substantially Equivalent
Time to decision
29 days
Received Apr 14, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K251138
- Device name
- Promisemed Safety Huber Needles
- Applicant location
- Hangzhou City, CN
- Received
- Apr 14, 2025
- Decided
- May 13, 2025
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device type
- Non-Coring (Huber) Needle (PTI)
- Device class
- Class II
- Regulation
- 21 CFR 880.5570
- Specialty
- Hospital Medicine & Nursing
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code PTI. The earliest in FDA's data is K162271, decided Apr 26, 2017.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K251138
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Promisemed Hangzhou Meditech Co., Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261719 · Decided Aug 25, 2026 · 91 days after receipt
Device type: Needle, Hypodermic, Single Lumen (FMI) · Hospital Medicine & Nursing
K261196 · Decided May 12, 2026 · 29 days after receipt
Device type: Instrument, Biopsy (KNW) · GI, Urology & Nephrology
- Verifine Safety Lancets510(k)
K261045 · Decided May 1, 2026 · 31 days after receipt
Device type: Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature (FMK) · General & Plastic Surgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.